Gly-Thr-OH

CAS : 7093-70-1

Ref. 3D-FG49320

Informations sur le produit

• Nom: Gly-Thr-OH
• Synonymes: (2S,3R)-2-(2-Aminoacetamido)-3-hydroxybutanoic acidGlycyl-L-threonine, 146: PN: US20130123467 SEQID: 175 claimed protein, 16: PN: WO2021055880 SEQID: 17 claimed protein, 23: PN: WO2020097235 SEQID: 252 claimed protein, 2: PN: WO03052099 PAGE: 83 claimed protein, 30: PN: WO2020185850 SEQID: 30 claimed protein, 437: PN: WO2005081628 SEQID: 439 claimed protein, 8: PN: WO2014170713 SEQID: 108 claimed protein, <span class="text-smallcaps">L</span>-Threonine, N-glycyl-, <span class="text-smallcaps">L</span>-Threonine, glycyl-, Gly-<span class="text-smallcaps">L</span>-thr, Gly-Thr, Glycyl-<span class="text-smallcaps">L</span>-threonine, Glycyl-L-threonine, Glycylthreonine, Threonine, N-glycyl-, Threonine, N-glycyl-, <span class="text-smallcaps">L</span>-

Description

Gly-Thr-OH is a cyclic peptide that is the product of a synthetic gene. This peptide has been shown to inhibit protein synthesis in target cells and to inhibit cancer cell growth. It also disrupts the normal function of a number of biomolecules, including DNA replication and transcription. Gly-Thr-OH has been shown to bind to dna and RNA, and may have potential as an anti-cancer drug.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 176.17 g/mol
• Formule: C₆H₁₂N₂O₄
• Degré de pureté: Min. 95%